{
    "clinical_study": {
        "@rank": "97462", 
        "arm_group": {
            "arm_group_label": "Treatment", 
            "arm_group_type": "Experimental", 
            "description": "Cat-PAD and Placebo"
        }, 
        "brief_summary": {
            "textblock": "Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects"
        }, 
        "brief_title": "Paediatric Safety Study in Cat-PAD", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Rhinoconjunctivitis", 
        "condition_browse": {
            "mesh_term": "Conjunctivitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Inclusion Criteria\n\n               -  Male or female, aged 5-12 years.\n\n               -  Moderate to severe rhinoconjunctivitis on exposure to cats for at least 2 years.\n\n               -  Subjects may optionally also have GINA Step 1 controlled asthma.\n\n               -  Positive skin prick test to cat hair.\n\n               -  Cat dander specific IgE \u22650.35 kU/L.\n\n          -  Exclusion Criteria\n\n               -  Asthma falling under the GINA definitions \"partly controlled\" and \"uncontrolled\"\n                  or Steps 2 to 5.\n\n               -  FEV1 <80% of predicted.\n\n               -  Clinically relevant abnormalities detected on physical examination.\n\n               -  History of severe drug allergy, severe angioedema or anaphylactic reaction to\n                  food."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "11 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01921257", 
            "org_study_id": "CP009"
        }, 
        "intervention": [
            {
                "arm_group_label": "Treatment", 
                "intervention_name": "Cat-PAD", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Treatment", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Cat Allergy", 
            "Rhinoconjunctivitis"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Lawrence Sher, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Rolling Hills Estate", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90274"
                    }, 
                    "name": "Peninsula Research Associates Inc"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anthony Montanaro, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97202"
                    }, 
                    "name": "Allergy Associates Research Center"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects", 
        "overall_contact": {
            "email": "lorenz.huebner@inventivhealth.com", 
            "last_name": "Lorenz Hubner"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate the safety and tolerability of Cat-PAD in paediatric subjects aged 5 to <12 years.", 
            "measure": "Proportion and frequency of Adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "up to 36 weeks after start of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01921257"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Circassia Limited", 
        "sponsors": {
            "collaborator": {
                "agency": "inVentiv Health Clinical", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Circassia Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}